share_log

广济药业(000952.SZ):拟预挂牌转让控股子公司湖北广济医药科技有限公司90%股权

hubei guangji pharmaceutical (000952.SZ): intends to pre-list and transfer 90% equity of its holding subsidiary hubei guangji pharmaceutical technology co., ltd.

Gelonghui Finance ·  Sep 20 03:49

On September 20th, Guangji Pharmaceutical (000952.SZ) announced that in order to effectively utilize asset resources and realize asset value, the company plans to transfer 90% equity of its holding subsidiary Hubei Guangji Medical Technology Co., Ltd. through pre-listing transfer on Shanghai United Property Exchange in accordance with relevant regulations on state-owned property rights management. The transfer price will be based on the evaluation results filed after the formal listing transfer and will be determined after the corresponding approval procedures of the company are completed.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment